159 related articles for article (PubMed ID: 2894880)
1. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats.
Gardiner SM; Bennett T
Br J Pharmacol; 1988 Jan; 93(1):9-22. PubMed ID: 2894880
[TBL] [Abstract][Full Text] [Related]
2. Adrenoceptor mechanisms in the cardiovascular effects of cocaine in conscious squirrel monkeys.
Schindler CW; Tella SR; Goldberg SR
Life Sci; 1992; 51(9):653-60. PubMed ID: 1354322
[TBL] [Abstract][Full Text] [Related]
3. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.
John GW; Doxey JC; Walter DS; Reid JL
Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400
[TBL] [Abstract][Full Text] [Related]
4. Regional haemodynamic effects of noradrenaline injected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats: possible mechanisms of action.
Bachelard H; Harland D; Gardiner SM; Kemp PA; Bennett T
Neuroscience; 1992; 47(4):941-57. PubMed ID: 1579218
[TBL] [Abstract][Full Text] [Related]
5. Involvement of beta 2-adrenoceptors in the regional haemodynamic responses to bradykinin in conscious rats.
Gardiner SM; Kemp PA; Bennett T; Bose C; Foulkes R; Hughes B
Br J Pharmacol; 1992 Apr; 105(4):839-48. PubMed ID: 1324051
[TBL] [Abstract][Full Text] [Related]
6. Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats.
Branch CA; Knuepfer MM
J Pharmacol Exp Ther; 1992 Nov; 263(2):742-51. PubMed ID: 1359113
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
8. Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats.
Batin P; Gardiner SM; Compton AM; Kemp PA; Bennett T
Br J Pharmacol; 1991 Jun; 103(2):1585-91. PubMed ID: 1884112
[TBL] [Abstract][Full Text] [Related]
9. Are 5-HT receptors or beta-adrenoceptors involved in idazoxan-induced food and water intake?
Jackson HC; Nutt DJ
Neuropharmacology; 1992 Nov; 31(11):1081-7. PubMed ID: 1361965
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular responses of sinoaortic-denervated rats to intracerebroventricular injection of alpha 1- and alpha 2-adrenoceptor agonists.
Ricci D; Taira CA; Enero MA
Eur J Pharmacol; 1992 Mar; 212(2-3):195-200. PubMed ID: 1350994
[TBL] [Abstract][Full Text] [Related]
11. Adrenalectomy abolishes antagonism of alpha-adrenoceptor-mediated hypotension by a beta-blocker in conscious rats.
Tabrizchi R; Pang CC
Br J Pharmacol; 1990 Oct; 101(2):358-62. PubMed ID: 1979508
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Nichols AJ; Gellai M; Ruffolo RR
Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
[TBL] [Abstract][Full Text] [Related]
13. The effects of idazoxan and other alpha 2-adrenoceptor antagonists on urine output in the rat.
Jackson HC; Griffin IJ; Birkett SD; Nutt DJ
Br J Pharmacol; 1992 Jun; 106(2):443-6. PubMed ID: 1356562
[TBL] [Abstract][Full Text] [Related]
14. The alpha-adrenoceptor mediating the tubular actions of the renal nerves in spontaneously hypertensive and stroke-prone spontaneously hypertensive rats.
Akpogomeh BA; Johns EJ
J Auton Pharmacol; 1990 Aug; 10(4):201-12. PubMed ID: 1977748
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Yu SM; Hsu SY; Ko FN; Chen CC; Huang YL; Huang TF; Teng CM
Br J Pharmacol; 1992 Aug; 106(4):797-801. PubMed ID: 1356567
[TBL] [Abstract][Full Text] [Related]
16. Interaction of alpha- and beta-adrenergic receptor blocking agents: circulatory effects in the conscious rat.
Gomes C; Henning M; Persson B; Trolin G
Clin Exp Hypertens (1978); 1978; 1(2):141-65. PubMed ID: 39712
[TBL] [Abstract][Full Text] [Related]
17. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
Perrone MH; Hamel LT; Ferrari RA; Haubrich DR
J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic pressor activity of midaglizole, an alpha-2 adrenoceptor antagonist, in pithed rats.
Hirohashi M; Tamura K; Akashi A
Jpn J Pharmacol; 1990 Aug; 53(4):519-20. PubMed ID: 1976844
[TBL] [Abstract][Full Text] [Related]
19. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
Riva E; Mennini T; Latini R
Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
[TBL] [Abstract][Full Text] [Related]
20. GYKI-12743 a new postsynaptic vascular alpha-adrenoceptor antagonist.
Rabloczky G; Jaszlits L; Horváth E
Acta Physiol Hung; 1991; 77(3-4):257-67. PubMed ID: 1684485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]